1Jaffe N, Frei E, Watts H, et al. High-dose methotrexate in osteogenic sarcoma. A 5-year experience. Cancer Treat Rep, 1978,62:259-264.
2Meyers PA, Heller G, Healey JH, et al. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol, 1992,10:5-15.
3Picci P, Sangiorgi L, Rougraff BT, et al. Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma. J Clin Oncol, 1994,12:2699-2705.
4Mankin HJ, Gebhardt MC, Jennings LC, et al. Long-term results of allograft replacement in the management of bone tumors. Clin Orthop Relat Res, 1996 (324) : 86-97.
5Unwin PS, Cannon SR, Grimer RJ,et al. Aseptic loosening in cemented custom-made prosthetic replacement for bone tumours of the lower limb. J Bone Joint Surg Br, 1996,78:5-13.
6Mittermayer F, Krepler P, Dominkus M, et al. Long-term follow up of uncemented tumor endoprostheses for the lower extremity. Clin Orthop Relat Res, 2001 (388) : 167-177.
7Kawai A, Muschler GF, Lane JM, et al. Prosthetic knee replacement after resection of a malignant tumor of the distal part of the femur. J Bone Joint Surg Am,1998, 80:636-647.
8Kabukcuoglu Y, Grimer RJ, Tillman RM, et al. Endoprosthetic replacement for primary malignant tumors of the proximal femur. Clin Orthop Relat Res,1999(358) :8-14.
9Wunder JS,Ogilvie CM,Ferguson PC, et al. Functional outcome of endoprosthetic proximal femoral replacement. Clin Orthop Relat Res ,2004 (426) :44-48.
10Malawer MM, Bickels J, Meller I, et al. Reconstruction of hip stability after proximal and total femur resections. Clin Orthop Relat Res,2000(375) :218-230.
3Ahlmann ER, Menendez LR, Kermani C, et al. Survivorship and clinical outcome of modular endoprosthetic reconstruction for neoplastic disease of the lower limb [ J]. J Bone Joint Surg Br,2006, 88(7) :790-795.
